Mark Woon

Biochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Phased Whole-Genome Genetic Risk in a Family Quartet Using a Major Allele Reference Sequence”.

Phased Whole-Genome Genetic Risk in a Family Quartet Using a Major Allele Reference Sequence

PLoS Genetics(2011)10.1371/journal.pgen.1002280

N/A

7.5DataRank · unranked

148 citations

Rong Chen, Sergio P. Cordero, Kelly E. Ormond, Colleen Caleshu, Konrad J. Karczewski +33 more

Clinical assessment incorporating a personal genome

The Lancet(2010)10.1016/s0140-6736(10)60452-7

N/A

0.978DataRank · unranked

676 citations

Atul Janardhan Butte, Matthew T. Wheeler, Rong Chen, Teri E. Klein, Frederick E. Dewey +28 more

How to Run the Pharmacogenomics Clinical Annotation Tool (PharmCAT)

Clinical Pharmacology & Therapeutics(2022)10.1002/cpt.2790

N/A

0.700DataRank · unranked

13 citations

Katrin Sangkuhl, Karl Keat, Ryan Whaley, Mark Woon, Shefali S. Verma +7 more

Frequencies of pharmacogenomic alleles across biogeographic groups in a large-scale biobank

The American Journal of Human Genetics(2023)10.1016/j.ajhg.2023.09.001

N/A

0DataRank · unranked

36 citations

Katrin Sangkuhl, Ryan Whaley, Mark Woon, Karl Keat, Michelle Whirl‐Carrillo +3 more